Beximco Pharmaceuticals Ltd. (BXP)
LSE
Closed
Oct 7, 2026
Day's Range
51.4252 wk Range
0.4250Overview - BXP - Beximco Pharmaceuticals Ltd.
Key Statistics
Valuation
Enterprise Value
27.35B
P/E (Trailing)
‪4.49‬
P/E (Forward)
‪0.06‬
PEG Ratio
‪0.20‬
Price / Sales (TTM)
‪0.49‬
Price / Book
‪0.48‬
EV / EBITDA
‪2.28‬
Profitability
Gross Margin
‪49.13%‬
Profit Margin
‪16.04%‬
Operating Margin
‪20.29%‬
Return on Assets
‪9.22%‬
Return on Equity
‪14.71%‬
Ownership
Shares Outstanding
446.11M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.21%‬
Price stats
Beta
‪0.24‬
50-Day Avg
‪56.62‬
200-Day Avg
‪21.99‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Annual
Market Cap - BXP - Beximco Pharmaceuticals Ltd.
Peers - BXP - Beximco Pharmaceuticals Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- BXPLSEBeximco Pharmaceuticals Ltd.24.09BMarket Cap+18.52%52-week change4.50P/E (Trailing)‪16.04%‬Profit Margin
- HLNLSEHaleon plc2.88TMarket Cap-1.07%52-week change18.76P/E (Trailing)‪14.55%‬Profit Margin
- 0QFPLSEGedeon Richter Plc.1.74TMarket Cap+0.00%52-week change7.34P/E (Trailing)‪19.72%‬Profit Margin
- HIKLSEHikma Pharmaceuticals PLC332.26BMarket Cap-8.04%52-week change12.41P/E (Trailing)‪11.31%‬Profit Margin
- ROSELSERosebank Industries plc308.38BMarket Cap-14.42%52-week change—P/E (Trailing)‪-4.92%‬Profit Margin
- HCMLSEHUTCHMED (China) Limited187.71BMarket Cap-9.26%52-week change108.00P/E (Trailing)‪3.25%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB158.42BMarket Cap+36.33%52-week change45.80P/E (Trailing)‪15.54%‬Profit Margin
Profile Summary - BXP - Beximco Pharmaceuticals Ltd.
About
Beximco Pharmaceuticals Ltd. is a leading pharmaceutical company in Bangladesh, renowned for its wide-ranging production and distribution of various medications and healthcare solutions. The company plays a critical role in manufacturing generic pharmaceutical formulations and active pharmaceutical ingredients (APIs),…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
